164 related articles for article (PubMed ID: 29166843)
1. Stagnant contraceptive sales after the Zika epidemic in Brazil.
Bahamondes L; Ali M; Monteiro I; Fernandes A
Eur J Contracept Reprod Health Care; 2017 Oct; 22(5):381-383. PubMed ID: 29166843
[TBL] [Abstract][Full Text] [Related]
2. Contraceptive sales in the setting of the Zika virus epidemic.
Bahamondes L; Ali M; Monteiro I; Fernandes A
Hum Reprod; 2017 Jan; 32(1):88-93. PubMed ID: 27932442
[TBL] [Abstract][Full Text] [Related]
3. Comparison of contraceptive sales before and during the COVID-19 pandemic in Brazil.
Charles CM; Munezero A; Bahamondes LG; Pacagnella RC
Eur J Contracept Reprod Health Care; 2022 Apr; 27(2):115-120. PubMed ID: 35156489
[TBL] [Abstract][Full Text] [Related]
4. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
5. The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016-17 Zika virus outbreak.
Lathrop E; Romero L; Hurst S; Bracero N; Zapata LB; Frey MT; Rivera MI; Berry-Bibee EN; Honein MA; Monroe J; Jamieson DJ
Lancet Public Health; 2018 Feb; 3(2):e91-e99. PubMed ID: 29371100
[TBL] [Abstract][Full Text] [Related]
6. No-daily hormonal contraception today: general overview and application in specific clinical settings.
Bounous VE; Actis S; Rosso R; Giorgi M; Tiranini L; Nappi RE; Biglia N
Gynecol Endocrinol; 2023 May; 39(1):2214626. PubMed ID: 37199597
[TBL] [Abstract][Full Text] [Related]
7. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
8. [Information on advances in sciences and technology. Advances in contraceptive technology].
Andrade AT
Bol Cent Biol Reprod; 1993; 12(1):51-2. PubMed ID: 12345521
[TBL] [Abstract][Full Text] [Related]
9. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
10. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.
Secura GM; Allsworth JE; Madden T; Mullersman JL; Peipert JF
Am J Obstet Gynecol; 2010 Aug; 203(2):115.e1-7. PubMed ID: 20541171
[TBL] [Abstract][Full Text] [Related]
11. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
Mavranezouli I;
Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
[TBL] [Abstract][Full Text] [Related]
13. Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia.
Brunie A; Stankevitz K; Nwala AA; Nqumayo M; Chen M; Danna K; Afolabi K; Rademacher KH
Lancet Glob Health; 2021 Oct; 9(10):e1431-e1441. PubMed ID: 34474001
[TBL] [Abstract][Full Text] [Related]
14. Achieving cost-neutrality with long-acting reversible contraceptive methods.
Trussell J; Hassan F; Lowin J; Law A; Filonenko A
Contraception; 2015 Jan; 91(1):49-56. PubMed ID: 25282161
[TBL] [Abstract][Full Text] [Related]
15. Contraception for the older woman.
Guillebaud J
J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S70-7. PubMed ID: 12268772
[TBL] [Abstract][Full Text] [Related]
16. Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network.
Lathrop E; Hurst S; Mendoza Z; Zapata LB; Cordero P; Powell R; Green C; Moreno N; Jamieson DJ; Romero L
Obstet Gynecol; 2020 May; 135(5):1095-1103. PubMed ID: 32282596
[TBL] [Abstract][Full Text] [Related]
17. Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods.
Pace LE; Dusetzina SB; Keating NL
Med Care; 2016 Sep; 54(9):811-7. PubMed ID: 27213549
[TBL] [Abstract][Full Text] [Related]
18. [Historical survey of modern reversible contraceptive methods].
Mbabajende V
Imbonezamuryango; 1986 Apr; (5):14-7. PubMed ID: 12268230
[TBL] [Abstract][Full Text] [Related]
19. New contraceptives by the year 2000: promise and challenge.
Rinehart W
Asian Pac Popul Programme News; 1984 Dec; 13(4):13-6. PubMed ID: 12313700
[TBL] [Abstract][Full Text] [Related]
20. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
